Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipigon Pharmaceuticals AB | 548,887 | net | 12 Apr 2023 | tx 4+548,887 |
| Camurus AB | 376,625 | net | 15 Dec 2020 | tx 8+376,625 |
| Nanexa AB | 166,000 | net | 07 Jul 2021 | tx 2+166,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Apr 2023 | PURCHASE | Lipigon Pharmaceuticals AB | 114,286 | 3.50 SEK | |
| 17 Jun 2022 | PURCHASE | Lipigon Pharmaceuticals AB | 398,430 | 2.15 SEK | |
| 07 Jul 2021 | PURCHASE | Nanexa AB | 60,000 | 5.00 SEK | |
| 23 Jun 2021 | PURCHASE | Lipigon Pharmaceuticals AB | 20,000 | 7.40 SEK | |
| 21 Jun 2021 | PURCHASE | Lipigon Pharmaceuticals AB | 16,171 | 6.99 SEK | |
| 15 Dec 2020 | OTHER | Camurus AB | 75,000 | 0.00 SEK | deriv |
| 31 Aug 2020 | PURCHASE | Camurus AB | 30,000 | 44.70 SEK | derivfirst after silence |
| 12 Jun 2020 | GRANT_AWARD | Nanexa AB | 106,000 | 1.15 SEK | deriv |
| 26 Mar 2019 | GRANT_AWARD | Camurus AB | 1,625 | 42.00 SEK | |
| 28 May 2018 | GRANT_AWARD | Camurus AB | 40,000 | 12.83 SEK | |
| 28 May 2018 | GRANT_AWARD | Camurus AB | 40,000 | 13.00 SEK | |
| 02 Jun 2017 | PURCHASE | Camurus AB | 75,000 | 1275000.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 31 Aug 2020.